Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 7/20 | 0.44 |
| ▸ | ABL1 | P00519 | 1/20 | 0.39 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.39 |
| ▸ | BCR | P11274 | 1/20 | 0.39 |
| ▸ | RPS6KA2 | Q15349 | 1/20 | 0.38 |
| ▸ | GPR3 | P46089 | 1/20 | 0.37 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.37 |
| ▸ | CES1 | P23141 | 1/20 | 0.37 |
| ▸ | PGR | P06401 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 2/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29589092 | 1.00 | PDK2 (0.44) | PDK2ABL1ABCB1BCRRPS6KA2 | |
| SCHEMBL259184 | 1.00 | PDK2 (0.44) | PDK2ABL1ABCB1BCRRPS6KA2 | |
| SCHEMBL20159380 | 1.00 | PDK2 (0.44) | PDK2ABL1ABCB1BCRRPS6KA2 | |
| SCHEMBL29352894 | 1.00 | PDK2 (0.44) | PDK2ABL1ABCB1BCRRPS6KA2 | |
| SCHEMBL29353071 | 1.00 | PDK2 (0.44) | PDK2ABL1ABCB1BCRRPS6KA2 | |
| SCHEMBL30182778 | 1.00 | PDK2 (0.44) | PDK2ABL1ABCB1BCRRPS6KA2 | |
| SCHEMBL14769865 | 0.94 | PDK2 (0.41) | PDK2ABL1ABCB1BCRRPS6KA2 | |
| SCHEMBL19319141 | 0.94 | PDK2 (0.41) | PDK2ABL1ABCB1BCRRPS6KA2 | |
| SCHEMBL16996394 | 0.93 | PGR (0.40) | PDK2ABL1ABCB1BCRRPS6KA2 | |
| SCHEMBL16996425 | 0.93 | PDK2 (0.40) | PDK2ABL1ABCB1BCRRPS6KA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 245 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2478576-B9 | ORGANIC ELECTRONIC DEVICE AND DOPANT FOR DOPING AN ORGANIC SEMICONDUCTING MATRIX MATERIAL | OSRAM OLED GMBH (DE) | 2017-09-06 | — | — | EP | claimed |
| EP-2478576-B1 | ORGANIC ELECTRONIC DEVICE AND DOPANT FOR DOPING AN ORGANIC SEMICONDUCTING MATRIX MATERIAL | OSRAM OLED GMBH (DE) | 2017-05-31 | — | — | EP | claimed |
| EP-2443680-B1 | METHOD OF MANUFACTURING A HOLE TRANSPORT LAYER WITH P-DOPING | SIEMENS AG (DE) | 2016-08-10 | — | — | EP | claimed |
| US-8610113-B2 | Material for a hole transport layer with p-dopant | SIEMENS AKTIENGESELLSCHAFT (DE) | 2013-12-17 | — | — | US | claimed |
| US-20120146006-A1 | MATERIAL FOR A HOLE TRANSPORT LAYER WITH P-DOPANT | NOVALED GMBH (DE) | 2012-06-14 | — | — | US | claimed |
| US-12538704-B2 | 4H-imidazo[1,2-a]imidazoles for electronic applications | UDC IRELAND LIMITED (IE) | 2026-01-27 | — | — | US | disclosed |
| US-20250185502-A1 | ORGANIC OPTOELECTRONIC COMPONENT, ORGANIC FUNCTIONAL LAYER, AND METHOD FOR PRODUCING AN OPTOELECTRONIC COMPONENT | OSRAM OLED GMBH (DE) | 2025-06-05 | — | — | US | disclosed |
| WO-2025100171-A1 | CHARGE-TRANSPORTING VARNISH AND CHARGE-TRANSPORTING VARNISH FOR QUANTUM DOT ELECTROLUMINESCENT ELEMENT | 日産化学株式会社 | 2025-05-15 | — | — | WO | disclosed |
| US-12302747-B2 | Optoelectronic component, organic functional layer, and method for producing an optoelectronic component | OSRAM OLED GMBH (DE) | 2025-05-13 | — | — | US | disclosed |
| WO-2025084125-A1 | CHARGE-TRANSPORTING INK COMPOSITION AND INK COMPOSITION FOR UPPER LAYER FILM OF QUANTUM DOT LAYER | 日産化学株式会社 | 2025-04-24 | — | — | WO | disclosed |
| WO-2025041715-A1 | CHARGE-TRANSPORTING INK COMPOSITION AND SURFACE-TREATED METAL OXIDE NANOPARTICLE SOL | 日産化学株式会社 | 2025-02-27 | — | — | WO | disclosed |
| WO-2025033132-A1 | CHARGE-TRANSPORTING VARNISH AND METHOD FOR PRODUCING SAME | 日産化学株式会社 | 2025-02-13 | — | — | WO | disclosed |
| US-20110079273-A1 | PHOTOVOLTAIC DEVICES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2011-04-07 | — | — | US | disclosed |
| US-20110036971-A1 | PHOTOVOLTAIC DEVICES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2011-02-17 | — | — | US | disclosed |
| US-20100308306-A1 | Use of a Metal Complex as a P-Dopant for an Organic Semiconductive Matrix Material, Organic Semiconductor Material, and Organic Light-Emitting Diodes | OSRAM OPTO SEMICONDUCTORS GMBH (DE) | 2010-12-09 | — | — | US | disclosed |
| US-20100243998-A1 | SEMICONDUCTOR MATERIAL AND ORGANIC RECTIFIER DIODE | NOVALED GMBH (DE) | 2010-09-30 | — | — | US | disclosed |
| WO-2010097433-A1 | QUINONE COMPOUNDS AS DOPANTS IN ORGANIC ELECTRONICS | BASF SE (DE) | 2010-09-02 | — | — | WO | disclosed |
| WO-2010079051-A1 | SILYL AND HETEROATOM SUBSTITUTED COMPOUNDS SELECTED FROM CARBAZOLES, DIBENZOFURANS, DIBENZOTHIOPHENES AND DIBENZO PHOSPHOLES AND THE APPLICATION THEREOF IN ORGANIC ELECTRONICS | BASF SE (DE) | 2010-07-15 | — | — | WO | disclosed |
| WO-2009089472-A2 | PHOTOVOLTAIC DEVICES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2009-07-16 | — | — | WO | disclosed |
| WO-2009089470-A2 | PHOTOVOLTAIC DEVICES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2009-07-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12538704-B2 | 4H-imidazo[1,2-a]imidazoles for electronic applications | RIF1, NR2E1, NR3C1 | PDK2 2756/4885ABL1 917/4885ABCB1 2321/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.